Last updated on February 2018

Short Duration Treatment of Non-severe Community Acquired Pneumonia

Brief description of study

To investigate the non inferiority of a short lasting antibiotic treatment (3 days) when compared to a long lasting antibiotic treatment (8 days), at Day 15 after the beginning of treatment in terms of clinical efficacy, in adults admitted to emergency services for a non severe Community Acquired Pneumonia (PAC), who responded well to 3 days of beta-lactamin treatment (3GC or A/AC).

Clinical Study Identifier: NCT01963442

Contact Investigators or Research Sites near you

Start Over

Anne-Claude CREMIEUX, PH

CH Saint Denis
Saint Denis, France
  Connect »

Anne-Claude CREMIEUX, PH

CHU Bichat
Paris, France
  Connect »

Victoire De Lastours, Dr

CH Beaujon
Clichy, France
  Connect »

Anne-Claude CREMIEUX, PH

CH Argenteuil
Argenteuil, France
  Connect »

Gilles Pialoux, Dr

CH Tenon
Paris, France
  Connect »

Jean-Emmanuel Kahn, Dr

Foch Hospital
Suresnes, France
  Connect »

Benjamin WIPLOSZ, Pr

CH Bic tre
Le Kremlin Bicètre, France
  Connect »

Anne-Claude CREMIEUX, PH

CHU Ambroise Par
Boulogne-Billancourt, France
  Connect »

Benjamin DAVIDO, PH

Central Hospital Raymon Poincar
Garches, France
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.